$16.57
0.160.94%
Last update: Oct 27, 3:32 PM
Hercules Capital Inc (HTGC) Stock Price, Quote, News & History
HTGCNYSE
Merck reportedly offered over $3 billion for MoonLake Immunotherapeutics, targeting its late-stage inflammatory drug as it faces revenue pressure from...
You can purchase shares of Hercules Capital (NYSE:HTGC) through any online brokerage.
Other companies in Hercules Capital’s space includes: BlackRock Inc (NYSE:BLK), Bank of New York Mellon Corp (NYSE:BNY), Blackstone Inc (NYSE:BX), Brookfield Corp (NYSE:BN) and KKR & Co Inc (NYSE:KKR).
Hercules Capital has a consensus price target of $19.35.
The stock price for Hercules Capital (NYSE: HTGC) is $16.565 last updated October 27, 2026 at 3:32 PM EDT.
There are no upcoming dividends for Hercules Capital.
Hercules Capital does not have any upcoming earnings scheduled.
There is no upcoming split for Hercules Capital.
Hercules Capital is in the Financials sector and Capital Markets industry. They are listed on the NYSE.
Hercules Capital Inc is a specialty finance company focused on providing senior secured loans to high-growth, venture capital-backed, and institutional-backed companies in a variety of technology and life sciences industries. The company's primary...
